Illumina seeks to dismiss shareholder lawsuit, denies secret $800M stakenews2024-11-15T19:18:46+00:00November 15th, 2024|Endpoints News|
Lilly sues US government over proposed 340B rebate modelnews2024-11-15T04:12:18+00:00November 15th, 2024|Endpoints News|
Louisiana’s Bill Cassidy named next chair of Senate health committeenews2024-11-14T18:05:52+00:00November 14th, 2024|Endpoints News|
J&J takes 340B fight with federal government to courtnews2024-11-13T16:34:31+00:00November 13th, 2024|Endpoints News|
Aurion, Alcon enter legal battle over IPO plannews2024-11-11T11:30:23+00:00November 11th, 2024|Endpoints News|
New Trump era could be a boon for biopharma M&A, dealmakingnews2024-11-06T12:22:52+00:00November 6th, 2024|Endpoints News|
BMS, J&J and AstraZeneca plea with appeals court to overturn drug price negotiationsnews2024-11-01T18:36:49+00:00November 1st, 2024|Endpoints News|
Heritage and Apotex to pay $49.1M in price-fixing settlementnews2024-11-01T16:36:10+00:00November 1st, 2024|Endpoints News|
Teva fined €462.6M over Copaxone patent and competition allegationsnews2024-10-31T19:25:03+00:00October 31st, 2024|Endpoints News|
Federal court backs FDA approval of Jazz sleep drug competitornews2024-10-31T19:16:47+00:00October 31st, 2024|Endpoints News|
